Making Natural Protein Production Faster and More Reliable

What is it about?

This study improved an earlier protein production method so bacteria could add natural chemical tags to more than half of all human proteins. It also introduced a simple screening system to help researchers discover new medicines that affect protein behaviour.

Featured Image

Why is it important?

This study transformed an earlier proof-of-concept into a practical research platform. By expanding the technology to include two major protein-modifying systems, the authors made it possible to produce correctly modified versions of more than half of all eukaryotic proteins in bacteria, often with complete efficiency. The improved method also increased reliability and introduced sequential expression to maximise modification before proteins were purified. The paper went further by demonstrating that the technology could be combined with a fluorescence-based assay to screen for compounds that influence protein behaviour, using the Parkinson's disease protein α-synuclein as an example. This expanded the platform beyond protein production into drug discovery and functional screening. Together, these advances made amino-terminal acetylation a routine part of recombinant protein production rather than a specialised laboratory technique. The work provided researchers with a practical and affordable way to study proteins in forms that more accurately reflect their natural state, while opening new opportunities for investigating diseases associated with protein folding, aggregation and regulation. It established the acetylation platform as a versatile enabling technology for both basic and applied bioscience.